Biomedical Diagnostics (BMD) is active in distribution, sales and marketing of high level in vitro diagnostics products and instrumentation in the Benelux.

BMD specializes in Auto-Immunity, Microbiology for infectious diseases, quality controls and monitoring of biotherapies.

BMD is located in Belgium from which it also serves The Netherlands, and is part of the Eurobio Scientific Group since June 2022.

Diagnostic International Distribution has focused on the distribution of in vitro diagnostic products (IVD) mainly dedicated to microbiology laboratories: dehydrated and ready-to-use media, swabs for collection and transport, antigens and antisera for serological investigations, diagnostic kits for the diagnosis of infectious diseases, bacterial identification systems, laboratory instruments since 1973.

The company operates in both clinical and industrial fields and is part of the Eurobio Scientific Group since July 2023.

Founded in 1994, GenBio is an experienced, fully integrated medical diagnostics company focused on the diagnosis of infectious diseases and autoimmune diseases. The company develops, manufactures and markets lines of serology products for infectious diseases and autoimmunity in accordance with US FDA and ISO 13485 standards. These products are intended to identify the presence of antibodies directed against specific infectious and autoimmune diseases.

Genbio is located north of San Diego, California, and has been part of the Eurobio Scientific Group since July 2017.

Specialized in molecular transplant diagnostics, GenDx develops and offers a comprehensive line of reagents and services, analysis software, and education.

GenDx is a pioneer in the area of Sequencing-Based Typing (SBT) for transplantation, offering high resolution HLA typing methods for Sanger and NGS platforms.

GenDx is located in the Netherlands and the US, it is part of the Eurobio Scientific Group since October 2022.

The Swiss-based TECOmedical Group is a leading provider of in-vitro speciality test systems in the areas of medical and veterinary diagnostic, biosafety and environmental testing. In addition it develops and evaluates new test systems in collaboration with opinion leaders or as service to pharma, CRO and research organizations.

TECOmedical is located in Switzerland and Germany. It also covers Austria, and is part of the Eurobio Scientific Group since July 2020.

In transplantation, the group commercializes media for the transportation and preservation of cornea grafts as well as a device to facilitate the corresponding surgery.

The group also commercializes AlloMap, a molecular test for the surveillance of heart-transplant patients, under an exclusive license for Europe.

In life-science, the group develops several products for R&D, targeting both government research organizations and the pharmaceutical industry. Eurobio Scientific commercializes cell culture media, molecular biology reagents as well as proprietary antibodies.

Combining its own laboratory and a strong industrial expertise, the company also offers a service dedicated to manufacturing tailor-made products for the biotechnology and pharmaceutical industries.

For infectious diseases, the group is currently marketing several proprietary products, including TQS™ (Tetanus Quick Stick) for the evaluation of patients immune status against tetanus, and the EBX molecular biology family which includes a range of tests aiming at identifying many pathogens responsible for infectious diseases and assessing the magnitude of the infection.

An Oncology activity providing a wide range of distribution products in the field of onco-hematology and genetics, making Eurobio Scientific a key player in the screening of mutations responsible for different forms of cancer and genetic diseases. We are also extremly excited with EndoPredict®, a genomic test for breast cancer patients, and Prolaris® Kits, a prognostic test for prostate cancer patients joining the Eurobio Scientific portfolio.